Evidence map›Paper›PMID 35820038›Full record

ArticleHuman vaccines & immunotherapeutics2022

Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China.

Huakun Lv, Xuejiao Pan, Ying Wang, Hui Liang, Hu Yu

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Huakun LvInstitute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
Xuejiao PanInstitute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
Ying WangInstitute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
Hui LiangInstitute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
Hu YuInstitute of Immunization and Prevention, Zhejiang Center for Disease Control and Prevention, Hangzhou, China.
Zhejiang Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesA cross-sectional survey was conducted among healthcare workers (HCWs) to assess their knowledge, attitude, and reporting behavior in adverse event following immunization (AEFI) surveillance as well as to identify barriers.

methodsA simple random sample of 170 vaccination clinics was selected and one HCW was informed to participate in this survey in each selected vaccination clinic. The survey was developed using a secure online platform and consisted of a structured online questionnaire. The distributions of the respondents' characteristics were presented. Training status, knowledge, attitude, and reporting behavior were compared between sub-groups of HCWs. Barriers and suggestions on AEFI reporting were also summarized.

resultsOf the 170 surveyed HCWs, 61.76% received the training on AEFI surveillance while 15.88% had no AEFI training at all. The higher level of knowledge and the more positive attitude and reporting behavior on AEFI surveillance were observed among HCWs with the longer working duration on AEFI surveillance, or among HCWs who received the training. The most critical barrier to reporting an AEFI was 'not being sure if the AEFI is related to the vaccine' (122, 71.76%). Other barriers were: 'I do not want to raise unnecessary public alarm about a vaccine' (105, 61.76%); 'reporting form or other method being too complicated' (65, 38.23%).

conclusionThe study findings highlighted the need to prioritize training on AEFI surveillance for HCWs. It is recommended that the development of the targeted interventions to strengthen AEFI surveillance system be required based on the barriers found in this study.

Indexed as

Adverse Drug Reaction Reporting SystemsVaccinesChinaCross-Sectional StudiesHealth PersonnelHealth Services AccessibilityHumansImmunizationVaccinationVaccinesAdverse events following immunizationbarriersafetysurveillancevaccines

Identifiers

PMID35820038
PMCPMC9621061
OpenAlexW4285093138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.